［1］Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012\[J\]. Crit Care Med, 2013, 41(2):580-637.［2］Guillamet MC, Rhee C, Patterson AJ, et al. Cardiovascular management of septic shock in 2012\[J\]. Curr Infect Dis Rep, 2012, 14(5): 493-502.［3］Miller AH, Nazeer S, Pepe P, et al. Acutely decompensated heart failure in a county emergency department: a doubleblind randomized controlled comparison of nesiritide versus placebo treatment\[J\]. Ann Emerg Med, 2008, 51(5): 571-578.［4］Yancy CW, Krum H, Massie BM, et al. Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: results of the Second FollowUp Serial Infusions of Nesiritide (FUSION Ⅱ) trial\[J\]. Circ Heart Fail, 2008, 1(1): 9-16.［5］VieillardBaron A. Septic cardiomyopathy\[J\]. Ann Intensive Care, 2011, 1(1): 6.［6］Zausig YA, Busse H, Lunz D, et al. Cardiac effects of induction agents in the septic rat heart\[J\]. Crit Care, 2009, 13(5): R144.［7］刘安雷，郭树彬，刘洁，等.脓毒症心功能障碍研究进展\[J\].中国急救医学，2011，31(9)：847-850.［8］王永清，樊寻梅.脓毒症及感染性休克时心肌抑制的炎症介质机制\[J\].小儿急救医学，2005, 12(2)：151-153.［9］Chappell D, HofmannKiefer K, Jacob M. TNFα induced shedding of the endothelial glycocalyx is prevented by hydrocortisone and antithrombin\[J\].Basic Res Cardiol, 2009, 104(1): 78-89.［10］Tavener SA, Kubes P. Is there a role for cardiomyocyte tolllike receptor 4 in endotoxemia?\[J\]. Trends Cardiovasc Med, 2005, 15(5)：153-157.［11］Clerico A, Recchia FA, Passino C, et al. Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications\[J\]. Am J Physiol Heart Circ Physiol, 2006, 290(1): H17-H29.［12］Fermepín MR, Vatta MS, Bianciotti LG, et al. BType and Ctype natriuretic peptides modify norepinephrine uptake in discrete encephalic nuclei of the rat\[J\]. Cell Mol Neurobiol, 2000, 20(6): 763-771.［13］童随阳，夏豪，王欣，等.重组人脑利钠肽治疗老年急性心肌梗死致心力衰竭临床效果和安全性研究\[J\].临床误诊误治,2015,28(8):72-77.［14］金莉子，董杰，马英东，等.新活素治疗对充血性心力衰竭患者NTproBNP及CRP的影响\[J\].中外医学研究，2011，9(28)：18-19.［15］Menon SG, Mills RM, Schellenberger U, et al. Clinical implications of defective Btype natriuretic peptide\[J\]. Clin Cardiol, 2009, 32(12): E36-E41.［16］Pan HY, Zhu JH, Gu Y, et al. Comparative effects of recombinant human brain natriuretic peptide and dobutamine on acute decompensated heart failure patients with differsent blood BNP levels\[J\]. BMC Cardiovasc Disord, 2014, 14: 31.［17］陈西洲. 重组人脑利钠肽辅助介入治疗对急性心肌梗死合并心源性休克患者预后的影响\[J\].海南医学院学报，2016，22(2)：133-137.［18］Yang H, Song Z, Jin H, et al. Protective effect of rhBNP on intestinal injury in the canine models of sepsis\[J\]. Int Immunopharmacol, 2014 ,19(2): 262-266.［19］Song Z, Cui Y, Ding MZ, et al. Protective effects of recombinant human brain natriuretic peptide against LPSInduced acute lung injury in dogs\[J\]. Int Immunopharmacol, 2013, 17(3): 508-512.
2017, Vol. 27 
